The study identifies clinically relevant resistance mutations in E. coli under subMIC antibiotic concentrations, showing that mutations in glpT, uhpT, uhpC, uhpA, nfsA, nfsB, gyrA, gyrB, and envZ confer resistance to fosfomycin, nitrofurantoin, ciprofloxacin, and tetracycline.